Inspiration of liver resection for hepatocellular carcinoma associated with hepatic vein invasion, not inferior vena cava invasion

Affiliations

Editorial

Nam-Joon Yi. Hepatobiliary Surg Nutr. 2018 Oct.

. 2018 Oct;7(5):392-394.

doi: 10.21037/hbsn.2018.07.02.

¹ Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.

No abstract available

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: A Japanese nationwide survey.
Kokudo T, Hasegawa K, Matsuyama Y, Takayama T, Izumi N, Kadoya M, Kudo M, Kubo S, Sakamoto M, Nakashima O, Kumada T, Kokudo N; Liver Cancer Study Group of Japan. Kokudo T, et al. Hepatology. 2017 Aug;66(2):510-517. doi: 10.1002/hep.29225. Epub 2017 Jun 26. Hepatology. 2017. PMID: 28437844

1. Bruix J, Raoul JL, Sherman M, et al. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial. J Hepatol 2012;57:821-9. 10.1016/j.jhep.2012.06.014 - DOI - PubMed
1. Kim KM, Kim JH, Park IS, et al. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion. J Gastroenterol Hepatol 2009;24:806-14. 10.1111/j.1440-1746.2008.05728.x - DOI - PubMed
1. Chung JW, Park JH, Han JK, et al. Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization. AJR Am J Roentgenol 1995;165:315-21. 10.2214/ajr.165.2.7618547 - DOI - PubMed
1. Kokudo T, Hasegawa K, Matsuyama Y, et al. Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion. J Hepatol 2016;65:938-43. 10.1016/j.jhep.2016.05.044 - DOI - PubMed
1. Lee KW, Suh SW, Choi Y, et al. Macrovascular invasion is not an absolute contraindication for living donor liver transplantation. Liver Transpl 2017;23:19-27. 10.1002/lt.24610 - DOI - PubMed